2022 Nevada Revised Statutes
Chapter 639 - Pharmacists and Pharmacy
NRS 639.28078 - Self-administered hormonal contraceptive: Conditions and requirements for dispensing; notification to Board; posting by Board of names of notifying pharmacies on Internet website. [Effective January 1, 2022.]
1. A pharmacist may dispense a self-administered hormonal contraceptive under the protocol established pursuant to NRS 639.28077 to a patient, regardless of whether the patient has obtained a prescription from a practitioner.
2. A pharmacist must provide the risk assessment questionnaire prescribed by the Board pursuant to NRS 639.28077 to a patient who requests a self-administered hormonal contraceptive before dispensing the self-administered hormonal contraceptive to the patient. If the patient completes the questionnaire and the results of the questionnaire indicate that it is unsafe to dispense the self-administered hormonal contraceptive to the patient, the pharmacist:
(a) Must not dispense the self-administered hormonal contraceptive; and
(b) Must refer the patient to the patient’s attending provider or another qualified provider of health care.
3. A pharmacist who dispenses a self-administered hormonal contraceptive under the protocol shall:
(a) Create a record concerning the dispensing of the self-administered hormonal contraceptive which includes, without limitation, the name of the patient to whom the self-administered hormonal contraceptive was dispensed, the type of self-administered hormonal contraceptive dispensed and any other relevant information required by the protocol prescribed pursuant to NRS 639.28077. The pharmacist or his or her employer shall maintain the record for the amount of time prescribed in that protocol.
(b) Inform the patient to whom the self-administered hormonal contraceptive is dispensed concerning:
(1) Proper administration and storage of the self-administered hormonal contraceptive;
(2) Potential side effects of the self-administered hormonal contraceptive; and
(3) The need to use other methods of contraception, if appropriate.
(c) Provide to the patient to whom the self-administered hormonal contraceptive is dispensed:
(1) The written record required by subsection 4; and
(2) Any written information required by the regulations adopted pursuant to NRS 639.28077.
(d) Comply with the regulations adopted pursuant to NRS 639.28077 and any guidelines for dispensing the self-administered hormonal contraceptive recommended by the manufacturer.
4. A pharmacist shall provide to any patient who requests a self-administered hormonal contraceptive under the protocol a written record of the request, regardless of whether the self-administered hormonal contraceptive is dispensed. The record must include, without limitation:
(a) A copy of the risk assessment questionnaire if completed by the patient pursuant to subsection 2; and
(b) A written record of the self-administered hormonal contraceptive requested and any self-administered hormonal contraceptive dispensed.
5. Any pharmacy that wishes to dispense self-administered hormonal contraceptives under the protocol must notify the Board of that fact. The Board shall post on an Internet website maintained by the Board a list of the names, addresses and contact information of pharmacies that have provided such notice.
6. As used in this section:
(a) "Attending provider" means a provider of health care who provides or has provided care to the patient.
(b) "Provider of health care" has the meaning ascribed to it in NRS 629.031.
(Added to NRS by 2021, 3269, effective January 1, 2022)
